Letter re: Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study

Eur J Cancer. 2023 Jan:178:68-69. doi: 10.1016/j.ejca.2022.10.010. Epub 2022 Oct 21.
No abstract available

Publication types

  • Observational Study
  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Causality
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Immunotherapy* / adverse effects
  • Patients

Substances

  • Immune Checkpoint Inhibitors